Bioaccessibility and Pharmacokinetics of a Commercial Saffron (Crocus sativus L.) Extract
There are few studies about the pharmacokinetics of the low-molecular mass carotenoids crocetin or crocin isomers from saffron (Crocus sativus L.). None has been performed with a galenic preparation of a standardised saffron extract. The aim of the present research work was to study the effect of in...
Main Authors: | Paula Almodóvar, David Briskey, Amanda Rao, Marín Prodanov, Antonio M. Inarejos-García |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Evidence-Based Complementary and Alternative Medicine |
Online Access: | http://dx.doi.org/10.1155/2020/1575730 |
Similar Items
-
Therapeutic Potential of Saffron Crocus (Crocus sativus L.)
by: Zeliha Selamoglu, et al.
Published: (2016-12-01) -
Saffron (Crocus sativus L.): As an antidepressant
by: Mohammad J Siddiqui, et al.
Published: (2018-01-01) -
Chemical Weed Control in Saffron (Crocus sativus) Fields
by: majid abbaspoor
Published: (2018-01-01) -
Therapeutic Potential of Saffron (Crocus sativus L.) in Ischemia Stroke
by: Shakiba Azami, et al.
Published: (2021-01-01) -
Traditional and Modern Uses of Saffron (<i>Crocus Sativus</i>)
by: Ibtissam Mzabri, et al.
Published: (2019-10-01)